Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-8448b6f56d-xtgtn Total loading time: 0 Render date: 2024-04-23T07:32:12.321Z Has data issue: false hasContentIssue false

4 - Retroviruses

from Section 1 - Agents

Published online by Cambridge University Press:  12 January 2010

By
Brian C. Dow ,
Eberhard W. Fiebig  and
Michael P. Busch
Edited by
John A. J. Barbara ,
Fiona A. M. Regan  and
Marcela Contreras
Brian C. Dow
Affiliation:
Consultant Clinical Microbiologist; Head, Scottish National Blood Transfusion Service, National Microbiology Reference Unit, West of Scotland, Transfusion Centre, Glasgow, UK
Eberhard W. Fiebig
Affiliation:
Associate Professor/Vice Chair, UCSF Department of Laboratory Medicine; Chief, Laboratory Medicine Service, San Francisco General Hospital, San Francisco, California, USA
Michael P. Busch
Affiliation:
Director, Blood Systems Research Institute; Vice President Research and Scientific Programs, Blood Systems, Inc.; Professor of Laboratory Medicine, University of California, USA
John A. J. Barbara
Affiliation:
University of the West of England, Bristol
Fiona A. M. Regan
Affiliation:
HNSBT and Hammersmith Hospitals NHS Trust, London
Marcela Contreras
Affiliation:
University of the West of England, Bristol
Get access

Summary

Retroviruses have a wide distribution in nature, with examples in insects, reptiles and nearly all mammals. The human retrovirus, human immunodeficiency virus (HIV 1 and 2), belongs to the lentivirus group of the retrovirus family, whilst human T-cell lymphotropic virus (HTLV I and II) belongs to the oncorna group. Human T-cell lymphotropic virus I and II are thought to have evolved from simian T-lymphotropic retroviruses that were transmitted to humans over the past centuries or millenia. Human immunodeficiency virus is thought to have derived from simian immunodeficiency viruses that are endemic in chimpanzees in Central Africa, and probably infected natives over the past century (Sharp et al., 2001).

Retroviruses are membrane-coated, single stranded RNA viruses that have a distinct genomic organization and require the presence of reverse transcriptase in their replication cycle. In a typical infection, retrovirus particles attach to the cell membrane, reverse transcriptase copies viral RNA into complementary double stranded DNA and this is integrated into the host cell chromosome. Host cell enzymes help virus and host regulatory genes complete the retrovirus lifecycle by producing virions that bud from the plasma membrane to infect other cells or organisms.

Human immunodeficiency viruses 1 and 2

Definition and characteristics of agent

Human immunodeficiency virus was discovered in the early 1980s by two groups of workers, Montagnier in France and Gallo in the USA. Originally described as human T cell lymphotropic virus type III (HTLV-III), the virus was shown to infect T-cell lymphocytes.

Type
Chapter
Information
Transfusion Microbiology , pp. 59 - 66
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Adler, M. W. (2001) ABC of AIDS: development of the epidemic. BMJ, 322, 1226–9.CrossRefGoogle ScholarPubMed
Apetrei, C., Loussert-Ajaka, I., Descamps, D., et al. (1996) Lack of screening test sensitivity during HIV-1 non-subtype B seroconversions. AIDS, 10, F57–60.CrossRefGoogle ScholarPubMed
Bharucha, Z. S. (2002) Risk management strategies for HIV in blood transfusion in developing countries. Vox Sang, 83 (Suppl. 1), 167–71.CrossRefGoogle ScholarPubMed
Busch, M. P. and Stramer, S. L. (1998) The efficiency of HIV p24 antigen screening of US blood donors: projections versus reality. Infusionsther und Transfusionmed, 25, 194–7.Google Scholar
Busch, M. P., Laycock, M., Kleinman, S. H., et al. and the Retrovirus Epidemiology Donor Study (REDS) (1994b) Accuracy of supplemental serological testing for human T-lymphotropic virus (HTLV) types I and II in US blood donors. Blood, 83, 1143–8.Google Scholar
Busch, M. P., Operskalski, E. A., Mosley, J. W., et al. and the Transfusion Safety Study Group (1994a) Epidemiological background and long-term course of disease in human immunodeficiency virus type 1-infected blood donors identified before routine laboratory screening. Transfusion, 34, 858–64.CrossRefGoogle Scholar
Busch, M. P., Operskalski, E. A., Mosley, J. W., et al. and the Transfusion Safety Study Group (1996) Factors influencing HIV-1 transmission by blood transfusion. J Infect Dis, 174, 26–33.CrossRefGoogle ScholarPubMed
Busch, M. P., Switzer, W. M., Murphy, E. L., et al. (2000) Absence of evidence of infection with divergent primate T-lymphotropic viruses in US blood donors who have seroindeterminate HTLV test results. Transfusion, 40, 443–9.CrossRefGoogle ScholarPubMed
Cesaire, R., Kerob-Bauchet, B., Bourdonne, O., et al. (2002) Evaluation of HTLV-I removal by filtration of blood cell components in a routine setting. Transfusion, 44, 42–8.CrossRefGoogle Scholar
Delwart, E. L., Kalmin, N. D., Jones, T. S., et al. (2004) First case of HIV transmission by an RNA-screened blood donation. Vox Sang, 86, 171–7.CrossRefGoogle ScholarPubMed
Delwart, E. L., Orton, S., Parekh, B., et al. (2003) Two per cent of HIV-positive US blood donors are infected with non-subtype-B strains. AIDS Res & Hum Retrovir, 19, 1065–70.CrossRefGoogle Scholar
Dodd, R. Y., Notari, E. P. IV. and Stramer, S. L. (2002) Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion, 42, 975–9.CrossRefGoogle ScholarPubMed
Dow, B. C., Munro, H., Ferguson, K., et al. (2001) HTLV antibody screening using mini-pools. Transfus Med, 11, 419–22.CrossRefGoogle ScholarPubMed
Fiebig, E. W., Wright, D. J., Rawal, B. D., et al. (2003) Dynamics of HIV viraemia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS, 17, 1871–9.CrossRefGoogle ScholarPubMed
Glynn, S. A., Kleinman, S. H., Wright, D. J., et al. (2002) International application of the incidence rate/window period model. Transfusion, 42, 966–72.CrossRefGoogle ScholarPubMed
Janssens, W., Buve, A. and Nkengasong, J. N. (1997) The puzzle of HIV-1 subtypes in Africa. AIDS, 11, 705–12.CrossRefGoogle ScholarPubMed
Learmont, J. C., Phillips, R. S. and Bickerton, I. J. (2002) The value of look-back to understanding blood-borne infectious diseases: the New South Wales' HIV experience. Transfus Med Rev, 16, 315–24.CrossRefGoogle Scholar
Ling, A. E., Robbins, K. E., Brown, T. M., et al. (2000) Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period. JAMA, 284, 210–4.CrossRefGoogle Scholar
Morris, K., Webb, B., Dow, B., et al. (2005) First HIV ‘window-period’ donation in a UK blood donor. Transfus Med, 15, 249–50.CrossRefGoogle Scholar
Murphy, E. L., Fridey, J., Smith, J. W., et al. (1997) HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. The REDS investigators. Neurology, 48, 315–20.CrossRefGoogle Scholar
Operskalski, E. A., Stram, D. O., Busch, M. P., et al. (1997) Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. Amer J Epid, 146, 655–61.CrossRefGoogle ScholarPubMed
Operskalski, E. A., Stram, D. O., Lee, H., et al. (1995) Human immunodeficiency virus type 1 infection: Relationship of risk group and age rate of progression to AIDS. Transfusion Safety Study Group. J Infect Dis, 172, 648–55.CrossRefGoogle ScholarPubMed
Parry, J. V., Murphy, G., Barlow, K. L., et al. (2001) National surveillance of HIV-1 subtypes for England and Wales: design, methods and initial findings. J Acquir Immune Defic Syndr, 26, 381–8.CrossRefGoogle ScholarPubMed
Peeters, M. (2004) Cross-species transmissions of simian retroviruses in Africa and risk for human health. Lancet, 363, 911–2.CrossRefGoogle ScholarPubMed
Pennington, J., Taylor, G. P., Sutherland, J., et al. (2002) Persistence of HTLV-I in blood components after leukocyte depletion. Blood, 100, 677–81.CrossRefGoogle ScholarPubMed
Pomper, G. J., Wu, Y. Y. and Snyder, E. L. (2003) Risks of tranfusion-transmitted infections: 2003. Curr Opin Haematol, 10, 412–8.CrossRefGoogle Scholar
Schable, C., Zekeng, L., Pau, C. P., et al. (1994) Sensitivity of US HIV antibody tests for detection of HIV-1 group O infections. Lancet, 344, 1333–4.CrossRefGoogle ScholarPubMed
Sharp, P. M., Bailes, E., Chaudhuri, R. R., et al. (2001) The origins of acquired immune deficiency syndrome viruses: where and when?Philos Trans R Soc Lond B Biol Sci, 356, 867–76.CrossRefGoogle ScholarPubMed
Simon, F., Loussert-Ajaka, I., Damond, F., et al. (1996) HIV type 1 diversity in northern Paris, France. Aids Res Hum Retroviruses, 12, 1427–33.CrossRefGoogle ScholarPubMed
Stramer, S. L., Glynn, S. A., Kleinman, S. H., et al. (2004) Detection of HIV and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. NEJM, 351, 760–8.CrossRefGoogle ScholarPubMed
Thorstensson, R., Albert, J. and Andersson, S. (2002) Strategies for diagnosis of HTLV-I and -II. Transfusion, 42, 780–91.CrossRefGoogle ScholarPubMed
Vrielink, H. and Reesink, H. W. (2004) HTLV-I/II prevalence in different geographic locations. Transfus Med Rev, 18, 46–57.CrossRefGoogle ScholarPubMed
Weber, B., Thorstensson, R., Tanprasert, S., et al. (2003) Reduction of the diagnostic window in three cases of human immunodeficiency-1 subtype E primary infection with fourth-generation HIV screening assays. Vox Sang, 85, 73–9.CrossRefGoogle Scholar
Weusten, J. J. A. M., Drimmelen, H. A. J. and Lelie, P. N. (2002) Mathematic modeling of the risk of HBV, HCV and HIV transmission by window-phase donations not detected by NAT. Transfusion, 42, 537–48.CrossRefGoogle Scholar
Whyte, G. S. (1997) Is screening of Australian blood donors for HTLV-I necessary?Med J Austral, 166, 478–81.Google ScholarPubMed
Wolfe, N. D., Switzer, W. M., Carr, J. K., et al. (2004) Naturally acquired simian retrovirus infections in central African hunters. Lancet, 363, 932–7.CrossRefGoogle ScholarPubMed
World Health Organization (2001) Global Database on Blood Safety, summary report 1998–1999. Available at: http//www.who.int/bloodsafety/global_database/en/SumRep_English.pdf

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Retroviruses
    • By Brian C. Dow, Consultant Clinical Microbiologist; Head, Scottish National Blood Transfusion Service, National Microbiology Reference Unit, West of Scotland, Transfusion Centre, Glasgow, UK, Eberhard W. Fiebig, Associate Professor/Vice Chair, UCSF Department of Laboratory Medicine; Chief, Laboratory Medicine Service, San Francisco General Hospital, San Francisco, California, USA, Michael P. Busch, Director, Blood Systems Research Institute; Vice President Research and Scientific Programs, Blood Systems, Inc.; Professor of Laboratory Medicine, University of California, USA
  • Edited by John A. J. Barbara, University of the West of England, Bristol, Fiona A. M. Regan, Marcela Contreras, University of the West of England, Bristol
  • Book: Transfusion Microbiology
  • Online publication: 12 January 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545245.008
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Retroviruses
    • By Brian C. Dow, Consultant Clinical Microbiologist; Head, Scottish National Blood Transfusion Service, National Microbiology Reference Unit, West of Scotland, Transfusion Centre, Glasgow, UK, Eberhard W. Fiebig, Associate Professor/Vice Chair, UCSF Department of Laboratory Medicine; Chief, Laboratory Medicine Service, San Francisco General Hospital, San Francisco, California, USA, Michael P. Busch, Director, Blood Systems Research Institute; Vice President Research and Scientific Programs, Blood Systems, Inc.; Professor of Laboratory Medicine, University of California, USA
  • Edited by John A. J. Barbara, University of the West of England, Bristol, Fiona A. M. Regan, Marcela Contreras, University of the West of England, Bristol
  • Book: Transfusion Microbiology
  • Online publication: 12 January 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545245.008
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Retroviruses
    • By Brian C. Dow, Consultant Clinical Microbiologist; Head, Scottish National Blood Transfusion Service, National Microbiology Reference Unit, West of Scotland, Transfusion Centre, Glasgow, UK, Eberhard W. Fiebig, Associate Professor/Vice Chair, UCSF Department of Laboratory Medicine; Chief, Laboratory Medicine Service, San Francisco General Hospital, San Francisco, California, USA, Michael P. Busch, Director, Blood Systems Research Institute; Vice President Research and Scientific Programs, Blood Systems, Inc.; Professor of Laboratory Medicine, University of California, USA
  • Edited by John A. J. Barbara, University of the West of England, Bristol, Fiona A. M. Regan, Marcela Contreras, University of the West of England, Bristol
  • Book: Transfusion Microbiology
  • Online publication: 12 January 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545245.008
Available formats
×